For: | Damiris K, Abbad H, Pyrsopoulos N. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World J Clin Oncol 2021; 12(5): 290-308 [PMID: 34131562 DOI: 10.5306/wjco.v12.i5.290] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v12/i5/290.htm |
Number | Citing Articles |
1 |
Tian Tian, Jian Ruan, Jia Zhang, Chun-Xia Zhao, Dong Chen, Jianzhen Shan. Nanocarrier-Based Tumor-Targeting Drug Delivery Systems for Hepatocellular Carcinoma Treatments: Enhanced Therapeutic Efficacy and Reduced Drug Toxicity. Journal of Biomedical Nanotechnology 2022; 18(3): 660 doi: 10.1166/jbn.2022.3297
|
2 |
Mingzhen Zhou, Baorui Liu, Jie Shen. Immunotherapy for hepatocellular carcinoma. Clinical and Experimental Medicine 2022; 23(3): 569 doi: 10.1007/s10238-022-00874-5
|
3 |
Meiling Fu, Jinxin Li, Zuodong Xuan, Zeyuan Zheng, Yankuo Liu, Zeyi Zhang, Jianzhong Zheng, Min Zhong, Bin Liu, Yifan Du, Lei Zhang, Huimin Sun. NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01805-5
|